Atelosteogenesis type I is a rare autosomal dominant condition.[1] This condition is evident at birth and is associated with a very poor prognosis for the baby. It may be diagnosed antenatally.
This condition is caused by mutations in the filamin B (FLNB) gene.[4][5][6]
Diagnosis
This condition is evident at birth and may be diagnosed antenatally with ultrasound or magnetic resonance imaging. The infants may be still born. Those that are live born do not survive long.[7]
This section is empty. You can help by adding to it. (July 2024)
Epidemiology
This section is empty. You can help by adding to it. (July 2024)
History
This condition was first described by Maroteaux et al. in 1982.[10]
References
^Sillence, D.; Worthington, S.; Dixon, J.; Osborn, R.; Kozlowski, K. (1997-05-13). "Atelosteogenesis syndromes: a review, with comments on their pathogenesis". Pediatric Radiology. 27 (5). Springer Science and Business Media LLC: 388–396. doi:10.1007/s002470050154. ISSN0301-0449. PMID9133349.
^Wessels, Annasu; Wainwright, Helen C.; Beighton, Peter (2011). "Atelosteogenesis Type I: Autopsy Findings". Pediatric and Developmental Pathology. 14 (6). SAGE Publications: 496–500. doi:10.2350/11-01-0969-cr.1. ISSN1093-5266. PMID21985323.
^Farrington-Rock, Claire; Firestein, Marc H.; Bicknell, Louise S.; Superti-Furga, Andrea; Bacino, Carlos A.; Cormier-Daire, Valerie; Le Merrer, Martine; Baumann, Clarisse; Roume, Joelle; Rump, Patrick; Verheij, Joke B.G.M.; Sweeney, Elizabeth; Rimoin, David L.; Lachman, Ralph S.; Robertson, Stephen P.; Cohn, Daniel H.; Krakow, Deborah (2006). "Mutations in two regions ofFLNBresult in atelosteogenesis I and III". Human Mutation. 27 (7). Hindawi Limited: 705–710. doi:10.1002/humu.20348. ISSN1059-7794. PMID16752402.
^Li, Ben C.; Hogue, Jacob; Eilers, Meg; Mehrotra, Pavni; Hyland, James; Holm, Tara; Prosen, Tracy; Slavotinek, Anne M. (2013). "Clinical report: Two patients with atelosteogenesis type I caused by missense mutations affecting the same FLNB residue". American Journal of Medical Genetics Part A. 161 (3): 619–625. doi:10.1002/ajmg.a.35792. ISSN1552-4825. PMID23401428.
^Stevenson, R.E; Wilkes, G (1983). "Atelosteogenesis with survival beyond the neonatal period". Proc. Greenwood Genet. Center 2: 32–38.
^Ueno, Kazunori; Tanaka, Mamoru; Miyakoshi, Kei; Zhao, Chen; Shinmoto, Hiroshi; Nishimura, Gen; Yoshimura, Yasunori (2002-10-24). "Prenatal diagnosis of atelosteogenesis type I at 21 weeks' gestation". Prenatal Diagnosis. 22 (12). Wiley: 1071–1075. doi:10.1002/pd.470. ISSN0197-3851. PMID12454961.
^Nishimurae, Gen; Horiuchi, Takashi; Kim, Ok H.; Sasamoto, Yuka (1997-12-12). "Atypical skeletal changes in otopalatodigital syndrome type II: Phenotypic overlap among otopalatodigital syndrome type II, boomerang dysplasia, atelosteogenesis type I and type III, and lethal male phenotype of Melnick-Needles syndrome". American Journal of Medical Genetics. 73 (2): 132–138. doi:10.1002/(SICI)1096-8628(19971212)73:2<132::AID-AJMG6>3.0.CO;2-W. PMID9409862.
^Maroteaux, P.; Spranger, J.; Stanescu, V.; Le Marec, B.; Pfeiffer, R. A.; Beighton, P.; Mattei, J. F.; Opitz, John M. (1982). "Atelosteogenesis". American Journal of Medical Genetics. 13 (1). Wiley: 15–25. doi:10.1002/ajmg.1320130106. ISSN0148-7299. PMID7137218.